Treatment with selective serotonin reuptake inhibitors during pregnancy: Deceleration of weight gain because of depression or drug?

American Journal of Psychiatry

Volumn 163, Issue 6, 2006, Pages 986-991

  Bodnar, Lisa M ^a   Sunder, Keerthy R ^a   Wisner, Katherine L ^a  

^a A742 Crabtree Hall ^*

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

CHILD DEVELOPMENT; CONFERENCE PAPER; DEPRESSION; FETUS DEVELOPMENT; FETUS GROWTH; HUMAN; PATIENT MONITORING; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; WEIGHT GAIN; ADULT; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; DIET THERAPY; DRUG EFFECT; EATING DISORDER; FEMALE; MAJOR DEPRESSION; METHODOLOGY; PREGNANCY COMPLICATION;

ADULT; DEPRESSIVE DISORDER, MAJOR; EATING DISORDERS; FEMALE; HUMANS; NUTRITION THERAPY; PREGNANCY; PREGNANCY COMPLICATIONS; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; WEIGHT GAIN;

EID: 85047696515     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.2006.163.6.986     Document Type: Conference Paper

References (21)

1. Chambers C, Johnson K, Dick L, Felix R, Jones K: Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996; 335:1010-1015
2. Simon GE, Cunningham ML, Davis RL: Outcomes of prenatal antidepressant exposure. Am J Psychiatry 2002; 159:2055-2061
3. Laine K, Heikkinin T, Ekblad U, Kero P: Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry 2003; 60:720-726
4. Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL: Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 2005; 293:2372-2383
5. Nulman I, Rovet J, Stewart DE, Wolpin J, Pace-Asciak P, Shuhaiber S, Koren G: Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 2002; 159:1889-1895
6. Wisner K, Gelenburg A, Leonard H, Zarin D, Frank E: Pharmacologic treatment of depression during pregnancy. JAMA 1999; 282:1264-1269
7. Institute of Medicine: Nutrition during Pregnancy. Washington, DC: National Academy Press; 1990
8. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P), version 2. New York, New York State Psychiatric Institute, Biometrics Research Department, 1996
9. Williams J, Terman M: Structured Interview Guide for the Hamilton Depression Rating Scale With Atypical Depression Supplement (SIGH-ADS). New York, New York State Psychiatric Institute, 2003
10. Hamilton M: A rating scale for depression. J Neurosurg Psychiatry 1960; 23:56-62
11. Wisner KL, Zarin DA, Holmboe ES, Appelbaum PS, Gelenberg AJ, Leonard HL, Frank E: Risk-benefit decision making for treatment of depression during pregnancy. Am J Psychiatry 2000; 157:1933-1940
12. Pastuszak A, Schick-Boschetto B, Zuber C, Feldkamp M, Pinelli M, Sihn S, Donnenfeld A, McCormack M, Leen-Mitchell M, Woodland C, et al: Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 1993; 269:2246-2248
13. Institute of Medicine: Nutrition During Pregnancy and Lactation: An Implementation Guide. Washington, DC, National Academy Press, 1992
14. Siega-Riz AM, Adair LS, Hobel CJ: Maternal underweight status and inadequate rate of weight gain during the third trimester of pregnancy increases the risk of preterm delivery. J Nutr 1996; 126:146-153
15. Hendrick V, Stowe ZN, Altshuler LL, Hwang S, Lee E, Haynes D: Placental passage of antidepressant medications. Am J Psychiatry 2003; 160:993-996
16. Wisner K, Stowe Z: Psychobiology of postpartum mood disorders. Semin Reprod Endocrinol 1997; 15:77-89
17. Weissman AM, Levy BT, Hartz AJ, Bentler S, Donohue M, Ellingrod VL, Wisner KL: Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry 2004; 161:1066-1078
18. Bayley N: Bayley Scales of Infant Development, 2nd ed. San Antonio, Tex, Psychological Corporation, 1993
19. Sussman N, Ginsberg D, Bikoff J: Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials. J Clin Psychiatry 2001; 62:256-260
20. Asberg-Wistedt A, Agren H, Ekselius L, Bengtsson F, Akerblad A: Sertraline versus paroxetine in major depression: clinical outcome after six months of continuous therapy. J Clin Psychopharmacol (Berl) 2000; 20:645-652
21. Kaiser LL, Allen L: Position of the American Dietetic Association: nutrition and lifestyle for a healthy pregnancy outcome. J Am Diet Assoc 2002; 102:1479-1490